PALISADE BIO, INC.

Profile

Company Names

PALISADE BIO, INC.
SENECA BIOPHARMA, INC.
NEURALSTEM, INC.

Addresses

7750 EL CAMINO REAL, SUITE 2A, CARLSBAD, CA 92009

7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA 92009

5800 ARMADA DRIVE, SUITE 210, CARLSBAD, CA 92008

20271 GOLDENROD LANE, STE 2024, GERMANTOWN, MD 20876

20271 GOLDENROD LANE, GERMANTOWN, MD 20876

20271 GOLDENROD LANE,, 2ND FLOOR, GERMANTOWN, MD 20876

20271 GOLDENROD LANE, 2ND FLOOR, GERMANTOWN, MD 20876

9700 GREAT SENECA HIGHWAY, ROCKVILLE, MD 20850

9700 GREAT SENECA HWY, ROCKVILLE, MD 20850

Phone Numbers

858-704-4900
(858) 704-4900
301-366-4841
3013664960
(301) 366-4960
301-366-4960

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$57,317,544.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2024-05-06 
$3,999,942.00 
$3,999,942.00 
$0.00 
Equity 
11
2024-02-01 
$2,502,717.00 
$2,502,717.00 
$0.00 
 
10
2023-04-05 
$4,003,205.00 
$4,003,205.00 
$0.00 
Equity 
9
2023-01-04 
$2,500,000.00 
$2,500,000.00 
$0.00 
 
8
2022-05-10 
$2,356,127.00 
$2,356,127.00 
$0.00 
 
7
2020-01-22 
$7,555,553.00 
$7,555,553.00 
$0.00 
 
6
2017-05-17 
$42,000.00 
$42,000.00 
$0.00 
Equity 
5
2016-12-12 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
4
2016-05-12 
$1,080,000.00 
$1,100,000.00 
$20,000.00 
Equity 
3
2014-10-28 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
2
2013-03-22 
$1,778,000.00 
$1,778,000.00 
$0.00 
Equity, Debt 
1
2009-12-30 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH 
 
CARTER 
EXECUTIVE OFFICER, DIRECTOR
NEODIAGNOSTIX INC   |  NEXIMMUNE, INC.   |  NOBLE LIFE SCIENCES, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  SENECA BIOPHARMA, INC.   |  BITMOVIN, INC.
JOHN 
 
CONRON 
EXECUTIVE OFFICER
NEURALSTEM, INC.
CRISTINA 
 
CSIMMA 
DIRECTOR
CYDAN, LLC   |  SENECA BIOPHARMA, INC.   |  PALISADE BIO, INC.
RICHARD 
 
DALY 
EXECUTIVE OFFICER, DIRECTOR
DNANEXUS, INC.   |  NEURALSTEM, INC.   |  FOOTPRINT INTERNATIONAL HOLDCO, INC.
STEPHANIE 
 
DIAZ 
DIRECTOR
LEADING BIOSCIENCES, INC.   |  PALISADE BIO, INC.
STEPHANIE 
C 
DIAZ 
DIRECTOR
PALISADE BIO, INC.
J.D. 
 
FINLEY 
EXECUTIVE OFFICER, DIRECTOR
ONLINE CHARITY SERVICES LLC   |  TAPESTRY INVESTORS LLC   |  GOLDMAIL INC   |  PALISADE BIO, INC.
JD 
 
FINLEY 
EXECUTIVE OFFICER
GREENFIELD R-M PARTNERS, LLC   |  LEADING BIOSCIENCES, INC.   |  PALISADE BIO, INC.
MARGERY 
 
FISCHBEIN 
DIRECTOR
CYTODEL, INC.   |  INHIBRX, INC.   |  PALISADE BIO, INC.
I. 
RICHARD 
GARR 
EXECUTIVE OFFICER, DIRECTOR
NEURALSTEM, INC.
RICHARD 
 
GARR 
DIRECTOR, EXECUTIVE OFFICER
NEURALSTEM, INC.
RICHARD 
I. 
GARR 
EXECUTIVE OFFICER, DIRECTOR
NEURALSTEM, INC.
MARY ANN 
 
GRAY 
DIRECTOR
ACADIA PHARMACEUTICALS INC   |  SAREPTA THERAPEUTICS, INC.   |  SENECA BIOPHARMA, INC.   |  PALISADE BIO, INC.
THOMAS 
 
HALLAM 
EXECUTIVE OFFICER, DIRECTOR
LEADING BIOSCIENCES, INC.   |  PALISADE BIO, INC.
KARL 
 
JOHE 
EXECUTIVE OFFICER, DIRECTOR
NEURALSTEM, INC.
MITCHELL 
 
JONES 
EXECUTIVE OFFICER
LENDTABLE INC   |  PALISADE BIO, INC.   |  POGO HOLDINGS INC.
JONATHAN 
 
LLOYD JONES 
EXECUTIVE OFFICER
NEURALSTEM, INC.
DAVID 
 
MAZZO 
DIRECTOR
CALADRIUS BIOSCIENCES, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  SENECA BIOPHARMA, INC.
ROBERT 
 
MCRAE 
EXECUTIVE OFFICER
PALISADE BIO, INC.
JAMES 
 
NEAL 
DIRECTOR
PALISADE BIO, INC.
JAMES 
R 
NEAL 
DIRECTOR
PALISADE BIO, INC.
SCOTT 
 
OGILVIE 
DIRECTOR
GENSPERA INC   |  NEURALSTEM, INC.   |  CHINA FOR-GEN CORP.   |  DERYCZ SCIENTIFIC INC   |  INSPYR THERAPEUTICS, INC.   |  SENECA BIOPHARMA, INC.
WILLIAM 
 
OLDAKER 
DIRECTOR
NEURALSTEM, INC.
HERBERT 
 
SLADE 
EXECUTIVE OFFICER
PALISADE BIO, INC.
SANDFORD 
 
SMITH 
DIRECTOR
BIOBEHAVIORAL DIAGNOSTICS CO   |  NEURALSTEM, INC.   |  SENECA BIOPHARMA, INC.
SANDFORD 
D. 
SMITH 
DIRECTOR
NEURALSTEM, INC.   |  APRICUS BIOSCIENCES, INC.
CATHERINE 
 
SOHN 
DIRECTOR
NEURALSTEM, INC.   |  RUBIUS THERAPEUTICS, INC.   |  LANDEC CORP \CA\   |  BIOECLIPSE THERAPEUTICS, INC.
CATHERINE 
A. 
SOHN 
DIRECTOR
NEURALSTEM, INC.   |  AXCELLA HEALTH INC.
ROBERT 
 
TRENSCHEL 
DIRECTOR
PALISADE BIO, INC.
BINXIAN 
 
WEI 
DIRECTOR
SENECA BIOPHARMA, INC.   |  PALISADE BIO, INC.
STANLEY 
 
WESTREICH 
DIRECTOR
VIGILANT SOLUTIONS, INC.   |  NEURALSTEM, INC.   |  VAAS INTERNATIONAL HOLDINGS, INC.
DONALD 
 
WILLIAMS 
DIRECTOR
MIRENCO INC   |  ALPHATEC HOLDINGS, INC.   |  AKARI THERAPEUTICS PLC   |  PALISADE BIO, INC.   |  FORTE BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-05-06 
2024-02-13
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2024-02-01 
2023-04-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-04-05 
2023-01-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2023-01-04 
2022-05-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2022-05-10 
2020-01-28
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2020-01-22 
2017-05-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-05-17 
2016-12-19
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-12-12 
2016-05-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-05-12 
2014-12-04
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2014-10-28 
2014-10-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2014-10-28 
2013-04-10
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Equity, Debt 
2013-03-22 
2010-01-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2009-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LADENBURG THALMANN + CO. INC.
000000505
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE
H.C. WAINWRIGHT + CO. LLC
375
NONE
NONE
TRIPOINT GLOBAL EQUITIES, LLC
143174
NONE
NONE
TRIPOINT GLOBAL EQUITIES, LLC
143174